Xiaoyuan Li

No. 19 Yuquan Road
Yuquan, 100049, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Assessing Graded Histological Regression as Basis for Treatment Modification after Neoadjuvant Therapy in LAGC: An Exploratory Phase II Study.

Assessing Graded Histological Regression as Basis for Treatment Modification after Neoadjuvant Therapy in LAGC: An Exploratory Phase II Study.

Journal: Annals of surgical oncology

Published: April 13, 2026

A Quantitative Modification of VI-RADS for Bladder Cancer at the Ureteral Orifice: A Reader Study on MRI With Varying Experience Levels.

A Quantitative Modification of VI-RADS for Bladder Cancer at the Ureteral Orifice: A Reader Study on MRI With Varying Experience Levels.

Journal: Journal of magnetic resonance imaging : JMRI

Published: March 24, 2026

High-titer antinuclear antibodies are associated with severe immune-related toxicity and exploratory survival outcomes in advanced gastric cancer immunotherapy.

High-titer antinuclear antibodies are associated with severe immune-related toxicity and exploratory survival outcomes in advanced gastric cancer immunotherapy.

Journal: Therapeutic advances in medical oncology

Published: January 30, 2026

Baseline IL-6 independently predicts severe immune-related toxicity and poor survival in advanced gastric cancer treated with immunotherapy.

Baseline IL-6 independently predicts severe immune-related toxicity and poor survival in advanced gastric cancer treated with immunotherapy.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: January 10, 2026

Preclinical and First-in-Human Study of Carbonic Anhydrase IX-Targeting Theranostic Pair, [68Ga]Ga/[177Lu]Lu-NYM096, in Clear Cell Renal Cell Carcinoma.

Preclinical and First-in-Human Study of Carbonic Anhydrase IX-Targeting Theranostic Pair, [68Ga]Ga/[177Lu]Lu-NYM096, in Clear Cell Renal Cell Carcinoma.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: November 04, 2025

[68Ga]Ga-NY104 PET/CT and [18F]FDG PET/CT in patients with metastatic clear cell renal cell carcinoma (NYCRM): A prospective, single-center, single-arm, comparative imaging trial.

[68Ga]Ga-NY104 PET/CT and [18F]FDG PET/CT in patients with metastatic clear cell renal cell carcinoma (NYCRM): A prospective, single-center, single-arm, comparative imaging trial.

Journal: European journal of nuclear medicine and molecular imaging

Published: October 31, 2025

Anti-PD-1 immunotherapy for the treatment of metastatic urothelial carcinoma in a kidney transplant recipient: a case report.

Anti-PD-1 immunotherapy for the treatment of metastatic urothelial carcinoma in a kidney transplant recipient: a case report.

Journal: BMC nephrology

Published: July 11, 2024

Emission and distribution characteristics of PCDD/Fs during the co-processing of various solid wastes in coal-fired boilers in China.

Emission and distribution characteristics of PCDD/Fs during the co-processing of various solid wastes in coal-fired boilers in China.

Journal: Environmental pollution (Barking, Essex : 1987)

Published: March 19, 2024

Diagnostic efficacy of [68Ga]Ga-NY104 PET/CT to identify clear cell renal cell carcinoma.

Diagnostic efficacy of [68Ga]Ga-NY104 PET/CT to identify clear cell renal cell carcinoma.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 18, 2024

Field-tested innovation: Sustainable utilization of secondary alumina dross for flash setting admixtures production.

Field-tested innovation: Sustainable utilization of secondary alumina dross for flash setting admixtures production.

Journal: Journal of environmental management

Published: November 22, 2023

A real-world analysis of trametinib in combination with hydroxychloroquine or CDK4/6 inhibitor as third- or later-line therapy in metastatic pancreatic adenocarcinoma.

A real-world analysis of trametinib in combination with hydroxychloroquine or CDK4/6 inhibitor as third- or later-line therapy in metastatic pancreatic adenocarcinoma.

Journal: BMC cancer

Published: May 11, 2023

Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma.

Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 17, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026